Antineoplastic and other hazardous drugs present a risk to health care personnel if they are not contained by appropriate facility design, personal protective equipment, and work practices that support safety. These drugs pose the risk of carcinogenicity and reproductive risks to personnel, which can be mitigated by using the proper containment practices.
Cardinal Health Innovative Delivery Solutions, Laflin, Pennsylvania.
Patricia C. Kienle, BScPharm, RPh, MPA, FASHP, is the director of accreditation and medication safety for Cardinal Health Innovative Delivery Solutions. She received a pharmacy degree from the Philadelphia College of Pharmacy and Science and a master's degree in public administration from Marywood University in Scranton, Pennsylvania. She is a current member of the USP Compounding Expert Committee and chairs its subcommittee on hazardous drugs.
Corresponding Author: Patricia C. Kienle, BScPharm, RPh, MPA, FASHP, Cardinal Health Innovative Delivery Systems, 106 Elmwood Drive, Laflin, PA 18702 (firstname.lastname@example.org).
The author has no conflicts of interest to disclose.
The author is a member of the USP Compounding Expert Committee, but these comments are her own and not those of USP.